Related Experiment Videos
Impact of Medical Treatment on Nasal Discharge in Chronic Rhinosinusitis: A Systematic Review and Meta-Analysis
Asher T Ripp1,2, Ethan M Kallenberger1, Shaun A Nguyen1
1Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, SC, USA.
Abstract:
BackgroundOne of the defining symptoms of chronic rhinosinusitis is nasal discharge. There are multiple treatment options, and the relative efficacy of each medication on discharge is unclear.ObjectiveTo characterize the effects of medical treatment on the various forms of nasal discharge in chronic rhinosinusitis.Review MethodsThe literature was searched from inception through 2024 for articles reporting nasal discharge symptom data both at baseline and after treatment with medical therapy. Specific symptoms of interest on the Sino-nasal Outcomes Test 22 (SNOT-22) were "Need to Blow Nose," "Runny Nose," "Postnasal Discharge," and "Thick Nasal Discharge." SNOT-22 scores ranged from 0 to 5 based on severity. Visual Analogue Scale equivalents were recorded when available.ResultsA total of 19 studies (n = 1758) were included. All four nasal discharge questions saw statistically significant improvement, with postnasal drip and thick nasal discharge seeing the largest degree of improvement (both -1.4 [95% CI: -2.3, -0.5). Both patients with polyps (-39.2 [-49.2, -29.2]) and without nasal polyps (-26.0 [-41.9, -10.1]) saw significant improvement in rhinorrhea. Only patients with polyps saw significant improvement in postnasal discharge (PND) (-30.1 [-47.5, -12.7]). Nasal polyp patients treated with biologics saw a mean decrease of 44.1 points [95% CI: 29.9-58.3] in their total SNOT, compared with 15.9 [95% CI: 8.8-22.9] and 14.5 [95% CI: 4.1-25.0] point decreases in standard and alternative medical treatments, respectively. Both biologic and standard medical treatments led to reductions in VAS Rhinorrhea, with biologics leading to a greater reduction (P = .03). Only patients receiving biologics underwent significant improvement in VAS PND scores.ConclusionIn chronic rhinosinusitis, all 4 types of nasal discharge reported on the SNOT-22 saw significant improvement. Both patients with polyps and without polyps see improvement in discharge. Treatment of nasal polyps with biologics results in significantly greater improvement in nasal discharge compared to standard medical therapy and alternative treatments.
Related Concept Videos
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Suctioning the Nasopharyngeal Airway
Equipment Required